Solasia Pharma K.K.

4597

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-13FY2026 Q2

Revenue

3.9100M JPY

YoY +32.4%

Operating Income

-5.7100M JPY

YoY -6.1%

Net Income

-9100M JPY

YoY +52.3%

EPS

-2.1JPY

YoY +15.7%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

10.9億円

1.8億円

-7.3億円

-16.4億円

-25.5億円

Rev: 5.6億円Op: -24.2億円NI: -24.8億円

Rev: 10.9億円Op: -24.7億円NI: -25.5億円

Rev: 6.2億円Op: -11.4億円NI: -11.1億円

Rev: 3.2億円Op: -19.5億円NI: -19.4億円

Rev: 4.3億円Op: -8.6億円NI: -8.8億円

2021/FY2022/FY2023/FY2024/FY2025/FY

Full-Year Progress

FY2026 Q2

Net Income-

Revenue Progress8M

Revenue Forecast-

Net Income Progress-5.800M

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan